Suzhou, China

Bin Huang

This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Evopoint Biosciences Co., Ltd., Suzhou Sinovent Pharmaceuticals Co., Ltd., Zumax Medical Co., Ltd.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bin Huang. Retrieved from https://idiyas.com/inventor/bin-huang-1b2uf84x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 8.9

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Bin Huang: A Glimpse into His Contributions

Introduction: Bin Huang is an accomplished inventor based in Suzhou, China, known for his significant contributions to the field of pharmaceuticals. With one notable patent to his name, Huang has made strides in developing a novel heterocyclic compound that showcases promising applications in medical science.

Latest Patents: Bin Huang's sole patent, titled "Heterocyclic compound, application thereof and pharmaceutical composition comprising same," represents a breakthrough in pharmaceutical research. The patent discloses a heterocyclic compound characterized by a novel structure, demonstrating potent inhibitory activity against autotaxin (ATX). This innovation has the potential to impact the development of new therapeutic solutions, emphasizing the importance of Huang's work in the industry.

Career Highlights: Currently, Bin Huang is affiliated with Suzhou Sinovent Pharmaceuticals Co., Ltd. His role at the company allows him to engage actively in research and development efforts aimed at pioneering new pharmaceutical advancements. His dedication to innovation is reflected in the strength of his patent and its applications.

Collaborations: Throughout his career, Bin Huang has collaborated with notable colleagues in the field, including Yonghan Hu and Dongdong Wu. These partnerships exemplify the collaborative nature of scientific advancement and highlight the importance of teamwork in achieving groundbreaking inventions.

Conclusion: Bin Huang's contributions to the pharmaceutical industry through his innovative heterocyclic compound patent signify an important step forward in medicinal chemistry. His work at Suzhou Sinovent Pharmaceuticals Co., Ltd., coupled with his collaborations, positions him as a significant figure in the ongoing development of effective therapeutic compositions. As the landscape of pharmaceuticals continues to evolve, innovators like Huang remain essential to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…